Raúl Adrover

Treatment with direct‐acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma

Federico Piñero, Manuel Mendizábal, Ezequiel Ridruejo et al. · Liver International · 2019 · 89 citations

Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents

Manuel Mendizábal, Federico Piñero, Ezequiel Ridruejo et al. · Clinical Gastroenterology and Hepatology · 2020 · 72 citations

Hepatology, Disease Progression, Hepatitis C +9

Breath-Ammonia Testing of Healthy Subjects and Patients with Cirrhosis

Raúl Adrover, Daniel Cocozzella, Ezequiel Ridruejo et al. · Digestive Diseases and Sciences · 2011 · 55 citations

Hepatology, Healthy Subjects, Medicine +4

31 SAFETY AND ANTIVIRAL ACTIVITY OF THE HCV NON-NUCLEOSIDE POLYMERASE INHIBITOR VX-222 IN TREATMENT-NAIVE GENOTYPE 1 HCV-INFECTED PATIENTS

M. Rodríguez‐Torres, E. Läwitz, Barbara R. Conway et al. · Journal of Hepatology · 2010 · 37 citations · Full text

Viral Hepatitis, Antiviral Drug Development, Antiviral Therapy +6

Relapse rates in chronic hepatitis <scp>B</scp> naïve patients after discontinuation of antiviral therapy with entecavir

Ezequiel Ridruejo, Sebastián Marciano, Omar Galdame et al. · Journal of Viral Hepatitis · 2013 · 29 citations

Hepatitis B, Autoimmune Liver Disease, Hepatic Disorders +18